Top

Published in:

01-10-2019 | Capsule Commentary

Capsule Commentary on Zueger et al., Older Medicare Beneficiaries Frequently Continue Medications with Limited Benefit Following Hospice Admission

Author: Rebecca Berger, M.D.

Published in: Journal of General Internal Medicine | Issue 10/2019

Excerpt

Zueger and colleagues¹ found that Medicare beneficiaries were often continued on “limited benefit medications” (LBM) after enrollment in hospice. …

Zueger PM, Holmes HM, Calip GS, Qato DM, Pickard S, Lee TA. Older Medicare Beneficiaries Frequently Continue Medications with Limited Benefit Following Hospice Admission. J Gen Intern Meed. https://doi.org/10.1007/s11606-019-05152-x.CrossRefPubMedPubMedCentral

Shega JW, Ellner L, Lau DT, Maxwell TL. Cholinesterase Inhibitor and N-Methyl-D-Aspartic Acid Receptor Antagonist Use in Older Adults with End-Stage Dementia: A Survey of Hospice Medical Directors. J Palliat Med. 2009;12(9):779–783. https://doi.org/10.1089/jpm.2009.0059.CrossRefPubMedPubMedCentral

Tjia J, Kutner JS, Ritchie CS, et al. Perceptions of Statin Discontinuation among Patients with Life-Limiting Illness. J Palliat Med. 2017;20(10):1098–1103. https://doi.org/10.1089/jpm.2016.0489.CrossRefPubMedPubMedCentral

Todd A, Husband A, Andrew I, Pearson S-A, Lindsey L, Holmes H. Inappropriate prescribing of preventative medication in patients with life-limiting illness: a systematic review. BMJ Support Palliat Care. 2016;7(2):113–121. https://doi.org/10.1136/bmjspcare-2015-000941.CrossRefPubMed

Tjia J, Briesacher BA, Peterson D, Liu Q, Andrade SE, Mitchell SL. Use of Medications of Questionable Benefit in Advanced Dementia. JAMA Intern Med. 2014;174(11):1763. https://doi.org/10.1001/jamainternmed.2014.4103.CrossRefPubMedPubMedCentral

Title: Capsule Commentary on Zueger et al., Older Medicare Beneficiaries Frequently Continue Medications with Limited Benefit Following Hospice Admission
Author: Rebecca Berger, M.D.
Publication date: 01-10-2019
Publisher: Springer International Publishing
Published in: Journal of General Internal Medicine / Issue 10/2019
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-019-05263-5

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Capsule Commentary on Zueger et al., Older Medicare Beneficiaries Frequently Continue Medications with Limited Benefit Following Hospice Admission

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 10/2019

Unearthing Faculty and Trainee Perspectives of Feedback in Internal Medicine: the Oral Case Presentation as a Model

Strengthening the Medical Error “Meme Pool”

Skin Bends: a Cutaneous Manifestation of Decompression Sickness

A Retrospective Cohort Study of the Effect of Hospitalist-Directed Transfers on Patient Flow

Frailty, Implantable Cardioverter Defibrillators, and Mortality: a Systematic Review

If You Listen, I Will Talk: the Experience of Being Asked About Suicidality During Routine Primary Care

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page